Cargando…
Within-host competition can delay evolution of drug resistance in malaria
In the malaria parasite P. falciparum, drug resistance generally evolves first in low-transmission settings, such as Southeast Asia and South America. Resistance takes noticeably longer to appear in the high-transmission settings of sub-Saharan Africa, although it may spread rapidly thereafter. Here...
Autores principales: | Bushman, Mary, Antia, Rustom, Udhayakumar, Venkatachalam, de Roode, Jacobus C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103507/ https://www.ncbi.nlm.nih.gov/pubmed/30130363 http://dx.doi.org/10.1371/journal.pbio.2005712 |
Ejemplares similares
-
On the Control of Acute Rodent Malaria Infections by Innate Immunity
por: Kochin, Beth F., et al.
Publicado: (2010) -
A general framework for modelling the impact of co-infections on pathogen evolution
por: Bushman, Mary, et al.
Publicado: (2019) -
Transmission stage investment of malaria parasites in response to in-host competition
por: Wargo, Andrew R, et al.
Publicado: (2007) -
Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections
por: de Roode, Jacobus C, et al.
Publicado: (2004) -
Which ‘imperfect vaccines’ encourage the evolution of higher virulence?
por: Bull, James J, et al.
Publicado: (2022)